Skip to content

Efficacy of Ayurved SIRIRAJ SAHATTHARA recipe, in patient with acute low back pain, the open-label randomized controlled trial

Efficacy of Ayurved SIRIRAJ SAHATTHARA recipe, in patient with acute low back pain, the open-label randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151118003
Enrollment
90
Registered
2015-11-18
Start date
2016-02-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute low back pain&#44

Interventions

Thai herbal medicine ,NSAIDs
Experimental Drug,Active Comparator Drug
Ayurved Siriraj Sahatsatara recipe (AVS023),Ibruprofen

Sponsors

Somruedee Chatsiricharoenkul
Lead Sponsor
Pinpilai Jutasompakorn
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - nonspecific acute low back pain without leg pain - pain duration less than 72 hours - pain score in numerical rating scale (NRS) are within 4-7

Exclusion criteria

Exclusion criteria: &#45; Pregnant or lactating women or positive pregnancy test women &#45; Blood pressure >140/90 mmHg &#45; History of spine trauma or surgery and osteoporosis. &#45; History of cardiovascular disease&#44; liver or renal impairment&#44; endocrine disorders&#44; neurological disease&#44; gastrointestinal disease and asthma. &#45; AST&#44; ALT> 2 time of UNL or CrCl < 50 mL/min &#45; Immunocompromised host &#45; Allergy to the study drug &#45; Volunteers who used NSAIDs or AVS 023 within 7 days before study participation and Corticosteroids within 4 weeks. &#45; Volunteers who used anti&#45;inflammatory drugs&#44; corticosteroids &#44; anticoagulant &#44; antiplatelet &#44; phenytoin &#44; theophylline &#44; rifampicin &#44; propranolol &#45; History of drug abuse.

Design outcomes

Primary

MeasureTime frame
pain reduction and improvement of disabilities 7 days numerical rating scale (NRS) and Oswestry disability index(ODI)

Secondary

MeasureTime frame
safety 7 days Adverse events and blood test including lCBC&#44; PT&#44; aPTT&#44; AST&#44; ALT&#44; BUN&#44; SCr

Countries

Thailand

Contacts

Public ContactSomruedee Chatsiricharoenkul

Department of pharmacology

somruedee.cha@mahidol.ac.th024197571

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026